121 related articles for article (PubMed ID: 17121933)
1. Targeting the active beta-catenin pathway to treat cancer cells.
Dvory-Sobol H; Sagiv E; Kazanov D; Ben-Ze'ev A; Arber N
Mol Cancer Ther; 2006 Nov; 5(11):2861-71. PubMed ID: 17121933
[TBL] [Abstract][Full Text] [Related]
2. Suppression of gastric cancer cell growth by targeting the beta-catenin/T-cell factor pathway.
Dvory-Sobol H; Sagiv E; Liberman E; Kazanov D; Arber N
Cancer; 2007 Jan; 109(2):188-97. PubMed ID: 17149756
[TBL] [Abstract][Full Text] [Related]
3. Gene therapy approach in prostate cancer cells using an active Wnt signal.
Giladi N; Dvory-Sobol H; Sagiv E; Kazanov D; Liberman E; Arber N
Biomed Pharmacother; 2007 Oct; 61(9):527-30. PubMed ID: 17904788
[TBL] [Abstract][Full Text] [Related]
4. Effective treatment of tumors with strong beta-catenin/T-cell factor activity by transcriptionally targeted oncolytic herpes simplex virus vector.
Kuroda T; Rabkin SD; Martuza RL
Cancer Res; 2006 Oct; 66(20):10127-35. PubMed ID: 17047077
[TBL] [Abstract][Full Text] [Related]
5. The suppression of colon cancer cell growth in nude mice by targeting beta-catenin/TCF pathway.
Kwong KY; Zou Y; Day CP; Hung MC
Oncogene; 2002 Nov; 21(54):8340-6. PubMed ID: 12447697
[TBL] [Abstract][Full Text] [Related]
6. Silibinin suppresses growth of human colorectal carcinoma SW480 cells in culture and xenograft through down-regulation of beta-catenin-dependent signaling.
Kaur M; Velmurugan B; Tyagi A; Agarwal C; Singh RP; Agarwal R
Neoplasia; 2010 May; 12(5):415-24. PubMed ID: 20454513
[TBL] [Abstract][Full Text] [Related]
7. Beta-catenin/Tcf-4 inhibition after progastrin targeting reduces growth and drives differentiation of intestinal tumors.
Pannequin J; Delaunay N; Buchert M; Surrel F; Bourgaux JF; Ryan J; Boireau S; Coelho J; Pélegrin A; Singh P; Shulkes A; Yim M; Baldwin GS; Pignodel C; Lambeau G; Jay P; Joubert D; Hollande F
Gastroenterology; 2007 Nov; 133(5):1554-68. PubMed ID: 17920061
[TBL] [Abstract][Full Text] [Related]
8. CARF activates beta-catenin/TCF signaling in the hepatocellular carcinoma.
Fan X; Ma X; Cui L; Dang S; Qu J; Zhang J; Wang X; Mao Z
Oncotarget; 2016 Dec; 7(49):80404-80414. PubMed ID: 27829235
[TBL] [Abstract][Full Text] [Related]
9. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1.
Satoh S; Daigo Y; Furukawa Y; Kato T; Miwa N; Nishiwaki T; Kawasoe T; Ishiguro H; Fujita M; Tokino T; Sasaki Y; Imaoka S; Murata M; Shimano T; Yamaoka Y; Nakamura Y
Nat Genet; 2000 Mar; 24(3):245-50. PubMed ID: 10700176
[TBL] [Abstract][Full Text] [Related]
10. Ad-PUMA sensitizes ovarian cancer cells to chemotherapeutic agents.
Luan QC; Sun YR; Han P; Chen Y
Eur Rev Med Pharmacol Sci; 2015 Dec; 19(23):4525-32. PubMed ID: 26698248
[TBL] [Abstract][Full Text] [Related]
11. Adenovirus-mediated overexpression FADD induces a significant antitumor effect on human colorectal cancer cells both in vitro and in vivo.
He X; Peng X; Liu Y; Zhang X; Li H; Yin H
Cell Mol Biol (Noisy-le-grand); 2018 May; 64(6):31-35. PubMed ID: 29808797
[TBL] [Abstract][Full Text] [Related]
12. C644-0303, a small-molecule inhibitor of the Wnt/β-catenin pathway, suppresses colorectal cancer growth.
Yan Y; Zhang Y; Li M; Zhang Y; Zhang X; Zhang X; Xu Y; Wei W; Wang J; Xu X; Song Q; Zhao C
Cancer Sci; 2021 Nov; 112(11):4722-4735. PubMed ID: 34431598
[TBL] [Abstract][Full Text] [Related]
13. Periplocin from Cortex periplocae inhibits cell growth and down-regulates survivin and c-myc expression in colon cancer in vitro and in vivo via beta-catenin/TCF signaling.
Zhao L; Shan B; Du Y; Wang M; Liu L; Ren FZ
Oncol Rep; 2010 Aug; 24(2):375-83. PubMed ID: 20596624
[TBL] [Abstract][Full Text] [Related]
14. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
[TBL] [Abstract][Full Text] [Related]
15. Suppression of neointima formation by targeting β-catenin/TCF pathway.
Williams H; Slater S; George SJ
Biosci Rep; 2016 Dec; 36(6):. PubMed ID: 27815507
[TBL] [Abstract][Full Text] [Related]
16. Regulation of Wnt signaling by the nuclear pore complex.
Shitashige M; Satow R; Honda K; Ono M; Hirohashi S; Yamada T
Gastroenterology; 2008 Jun; 134(7):1961-71, 1971.e1-4. PubMed ID: 18439914
[TBL] [Abstract][Full Text] [Related]
17. PUMA sensitizes lung cancer cells to chemotherapeutic agents and irradiation.
Yu J; Yue W; Wu B; Zhang L
Clin Cancer Res; 2006 May; 12(9):2928-36. PubMed ID: 16675590
[TBL] [Abstract][Full Text] [Related]
18. [Periplocin extracted from cortex periplocae induces apoptosis of SW480 cells through inhibiting the Wnt/beta-catenin signaling pathway].
Du YY; Liu X; Shan BE
Ai Zheng; 2009 May; 28(5):456-60. PubMed ID: 19624870
[TBL] [Abstract][Full Text] [Related]
19. Functional interaction of DNA topoisomerase IIalpha with the beta-catenin and T-cell factor-4 complex.
Huang L; Shitashige M; Satow R; Honda K; Ono M; Yun J; Tomida A; Tsuruo T; Hirohashi S; Yamada T
Gastroenterology; 2007 Nov; 133(5):1569-78. PubMed ID: 17983804
[TBL] [Abstract][Full Text] [Related]
20. Wnt/β-catenin signaling mediates the antitumor activity of magnolol in colorectal cancer cells.
Kang YJ; Park HJ; Chung HJ; Min HY; Park EJ; Lee MA; Shin Y; Lee SK
Mol Pharmacol; 2012 Aug; 82(2):168-77. PubMed ID: 22550094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
